Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.22) by 177.27 percent. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $6.98 million which missed the analyst consensus estimate of $7.00 million by 0.33 percent. This is a 26.32 percent decrease over sales of $9.47 million the same period last year.